… seeks to evaluate the cost-utility of adding cisplatin to standard gemcitabine therapy from a
… the cost-effectiveness of gemcitabine + cisplatin relative to gemcitabine monotherapy using …

… is to compare the cost-effectiveness of GP versus … gemcitabine 1 g/m 2 on days 1 and 8,
cisplatin 25 mg/m 2 on days 1–3, every three weeks) for three cycles followed by CCRT (cisplatin …

Purpose Compared with conventional fluorouracil plus cisplatin (FP) regimen, gemcitabine
plus cisplatin (GP) can prolong survival in patients with recurrent or metastatic …

… Based on these two trials, we present a cost-effectiveness analysis to compare
gemcitabine and cisplatin (GP) versus cisplatin, fluorouracil, and docetaxel (TPF) for induction …

… In this paper, we sought to determine the relative cost-effectiveness of the use of radiation
and cisplatin compared to radiation and gemcitabine/cisplatin in patients with advanced stage …

… This study assessed the cost-effectiveness of combination treatment with gemcitabine and
cisplatin compared to treatment with gemcitabine alone for advanced biliary tract cancer (BTC…

… world, treatments that are not cost effective will be inaccessible. With … cost effectiveness
(CE) of gemcitabine plus cisplatin and radiation followed by 2 cycles of gemcitabine and cisplatin …

… This study aimed to evaluate the cost-effectiveness of cisplatin plus gemcitabine vs. paclitaxel
plus gemcitabine as a first-line treatment for metastatic triple-negative breast cancer in …

… gemcitabine plus cisplatin (Gem/Cis) is at least as effective as several other chemotherapy
doublets such as vinorelbine plus cisplatin (Vin/Cis), paclitaxel plus cisplatin (… plus cisplatin (…

… The purpose of this study was to evaluate the cost-effectiveness of the combined use of
afatinib and epidermal growth factor receptor (EGFR) testing versus gemcitabine-cisplatin as the …